❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ Jørgen Wesche's group ❭ Internal group info ❭ Links to journals ❭

Journal home pages

Entrez Pubmed

ScienceDirect - Journals

EBSCOhost Electronic Journals Service


Elektroniske tidsskrifter MN

Elektroniske tidsskrifter UMH

Tidsskriftliste Bibsys


HighWire -- Access via Institution

Directory of open access journals

PubMed Central Home

Faculty of 1000 | Identifying the Best Biology Papers


Bioinformatics

BioMed Central | Home page

British Journal of Cancer

British Medical Journal

Cancer Cell Online

Cancer Research

Clinical Cancer Research

Developmental Cell -- Search

Development -- Search

EMBO Journal

EMBO Reports Online

Genes, Chromosomes and Cancer

Genome Biology | homepage

Genomics & Proteomics Archive

International Journal of Cancer

International Journal of Oncology

Journal Citation Reports

Journal of Biological Chemistry

Journal of Cellular Biochemistry

JNCI - Cancer Spectrum

Lancet

Nature

Nature Reviews

Nucleic Acids Research

Oncogene

Physiological Genomics

Proceedings of the National Academy of Sciences

Public Library of Science

Science Magazine Home

Tidsskrift for den Norske Lægeforening


 
Jun 25, 2004
Scroll to top

Home Dept. of Tumor Biology Jørgen Wesche's group

  • Research projects
  • Group members
  • Publications
  • News
  • Internal group info
    • Group meetings
    • Booking
    • Links to journals
    • Download presentations
  • Pasientinformasjon
  • Links

Recent publications

Bjørnerud B, Wesche J, Haugsten EM (2025)
A rhabdomyosarcoma cell migration inhibitor screen using phase-contrast microscopy
Exp Cell Res, 114582 (in press)
DOI 10.1016/j.yexcr.2025.114582, PubMed 40320199

Yip D, Zalcberg J, Blay JY, Eriksson M, Espinoza D, Price T, Marreaud S, Italiano A, Steeghs N, Boye K, Underhill C, Gebski V, Simes J, Gelderblom H, Joensuu H (2025)
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial
Br J Cancer (in press)
DOI 10.1038/s41416-025-02983-w, PubMed 40133509

Naolou T, Schadzek N, Hornbostel JM, Pepelanova I, Frommer M, Lötz F, Sauheitl L, Dultz S, Felde VJMNL, Myklebost O, Lee-Thedieck C (2025)
Enhanced gelatin methacryloyl nanohydroxyapatite hydrogel for high-fidelity 3D printing of bone tissue engineering scaffolds
Biofabrication, 17 (2)
DOI 10.1088/1758-5090/adbb90, PubMed 40020249



More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)